Uploaded November 2026 | Updated November 2026, 3 hours ago
Does testosterone replacement therapy (TRT) increase your risk of blood clots? What does the scientific research actually reveal?
In this video, we break down a major study published in the **BMJ**, led by Martinez and colleagues, investigating the relationship between testosterone therapy and venous thromboembolism (VTE).
The research found that:
- During the first six months of testosterone treatment, the rate ratio for VTE was 1.63.
- After more than six months, the rate ratio was 1.00.
- The estimated additional risk was approximately 10 VTE events per 10,000 person-years.
- The study highlights why understanding the timing of TRT initiation matters.
So, should men be worried about testosterone therapy and blood clots? Understanding absolute risk, relative risk and the limitations of observational research is essential.
Watch until the end to understand what these findings really mean.
**COMMENT BELOW:** Do you think men are given enough information about TRT risks before starting treatment?
Subscribe to Balance My Hormones for expert discussions about testosterone, TRT, HRT, peptides, hormone optimisation and longevity.
Visit: balancemyhormones.co.uk
Contact our consultants: +44-2039003209
*Educational content only. This video is not a substitute for individual medical advice. Never start, stop or change prescribed testosterone treatment without consulting your healthcare professional.*
#TRT #Testosterone #BloodClots #Hematocrit #TestosteroneReplacementTherapy #TRTForMen #LowTestosterone #HormoneReplacementTherapy
Does testosterone replacement therapy (TRT) increase your risk of blood clots? What does the scientific research actually reveal?
In this video, we break down a major study published in the **BMJ**, led by Martinez and colleagues, investigating the relationship between testosterone therapy and venous thromboembolism (VTE).
The research found that:
- During the first six months of testosterone treatment, the rate ratio for VTE was 1.63.
- After more than six months, the rate ratio was 1.00.
- The estimated additional risk was approximately 10 VTE events per 10,000 person-years.
- The study highlights why understanding the timing of TRT initiation matters.
So, should men be worried about testosterone therapy and blood clots? Understanding absolute risk, relative risk and the limitations of observational research is essential.
Watch until the end to understand what these findings really mean.
**COMMENT BELOW:** Do you think men are given enough information about TRT risks before starting treatment?
Subscribe to Balance My Hormones for expert discussions about testosterone, TRT, HRT, peptides, hormone optimisation and longevity.
Visit: balancemyhormones.co.uk
Contact our consultants: +44-2039003209
*Educational content only. This video is not a substitute for individual medical advice. Never start, stop or change prescribed testosterone treatment without consulting your healthcare professional.*
#TRT #Testosterone #BloodClots #Hematocrit #TestosteroneReplacementTherapy #TRTForMen #LowTestosterone #HormoneReplacementTherapy










